ABVC BioPharma, Inc. announced that at its annual meeting of shareholders held on May 20, 2022, elected Che Wei Hsu, Shuling Jiang and Kuang-Tseng Chen as directors to the Company's Board, with such directors to serve until the 2023 annual meeting of shareholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +7.43% | +51.43% | +37.07% |
1st Jan change | Capi. | |
---|---|---|
+37.07% | 15.59M | |
-2.26% | 104B | |
+1.41% | 97.42B | |
+0.79% | 22.2B | |
-17.84% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.63% | 15.06B | |
+4.55% | 13.98B | |
+32.11% | 11.66B |
- Stock Market
- Equities
- ABVC Stock
- News ABVC BioPharma, Inc.
- ABVC BioPharma, Inc. Announces Board Elections